CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 37 filers reported holding CANCER GENETICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $588,000 | -62.2% | 178,234 | -10.3% | 0.62% | -63.2% |
| Q3 2015 | $1,554,000 | -22.8% | 198,774 | +16.2% | 1.67% | -20.4% |
| Q2 2015 | $2,012,000 | +55.1% | 171,082 | +3.0% | 2.10% | +46.6% |
| Q1 2015 | $1,297,000 | +3.8% | 166,083 | -11.3% | 1.43% | +10.4% |
| Q4 2014 | $1,250,000 | – | 187,184 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DOMINI IMPACT INVESTMENTS LLC | 30,048 | $235,000 | 3.84% |
| Millrace Asset Group, Inc. | 198,774 | $1,554,000 | 1.67% |
| EAM Investors, LLC | 129,972 | $1,016,000 | 0.16% |
| TURNER INVESTMENTS LLC | 94,730 | $741,000 | 0.15% |
| Granite Investment Partners, LLC | 156,993 | $1,227,000 | 0.12% |
| Sterneck Capital Management, LLC | 20,030 | $157,000 | 0.10% |
| DIKER MANAGEMENT LLC | 28,815 | $225,000 | 0.05% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $117,000 | 0.03% |
| VANGUARD GROUP INC | 4,972,880 | $172,109,000 | 0.01% |
| DENVER INVESTMENT ADVISORS LLC | 14,141 | $111,000 | 0.01% |